SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-217039
Filing Date
2023-08-21
Accepted
2023-08-21 17:01:01
Documents
13
Period of Report
2023-08-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d535860d8k.htm   iXBRL 8-K 27552
2 EX-99.1 d535860dex991.htm EX-99.1 13886
  Complete submission text file 0001193125-23-217039.txt   174173

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA coya-20230818.xsd EX-101.SCH 2877
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE coya-20230818_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coya-20230818_pre.xml EX-101.PRE 11725
7 EXTRACTED XBRL INSTANCE DOCUMENT d535860d8k_htm.xml XML 3469
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41583 | Film No.: 231189854
SIC: 2834 Pharmaceutical Preparations